Repaglinide (1 mg) + Voglibose (0.2 mg) is an oral antidiabetic combination used to improve blood glucose control in adults with Type 2 Diabetes Mellitus. Repaglinide stimulates the pancreas to release insulin, particularly around mealtimes, while Voglibose slows the digestion and absorption of carbohydrates in the intestine, reducing the rise in blood sugar after meals. Together, they help control both fasting and postprandial (after-meal) blood glucose levels when used along with a healthy diet, regular exercise, and lifestyle modifications.
Indications :
- Type 2 Diabetes Mellitus
- Postprandial (after-meal) hyperglycemia
- Inadequate blood sugar control with diet and exercise alone
- Patients requiring dual oral antidiabetic therapy
- Helps improve overall glycemic control
Common Side Effects :
- Hypoglycemia (low blood sugar)
- Flatulence (gas)
- Abdominal discomfort
- Diarrhea
- Nausea
- Headache
- Dizziness
- Mild weight gain (occasionally)
Precautions :
- Use only under medical supervision.
- Monitor blood glucose levels regularly.
- Avoid skipping meals after taking the medication.
- Inform your doctor if you have liver or kidney disease.
- Use cautiously in elderly patients.
- Avoid excessive alcohol consumption as it may increase the risk of hypoglycemia.
- Inform your doctor about all other medicines you are taking.
- Not recommended during pregnancy or breastfeeding unless advised by a physician.
Storage :
- Store below 30°C in a cool, dry place.
- Protect from moisture and direct sunlight.
- Keep the tablets in their original blister pack until use.
- Keep out of reach of children and pets.
NOTE : TAKE THIS MEDICINE AS PER THE GUIDANCE OF HEALTHCARE PROFESSIONAL.
Keywords
